The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1065
November 5, 1999
View Complete Issue         Table of Contents 2019 
SAMe For Depression
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
SAMe For Depression
November 5, 1999 (Issue: 1065)
S-adenosyl-methionine (SAM; SAMe; ademetionine; adomet), an endogenous compound synthesized from methionine and adenosine-triphosphate (ATP), has been marketed in stores and on the internet as a dietary supplement to promote "emotional well being."
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: SAMe For Depression
Article code: 1065b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.